目的系统评价注射硬化剂聚桂醇(PPI)及无水乙醇(PEI)对甲状腺囊性结节的有效性及安全性。方法系统检索万方数据知识平台、中国生物医学文献数据库(CBM)、中国期刊全文数据库(CNKI)、Web of Science、the Cochrane Library、EmBase和Pub...
详细信息
目的系统评价注射硬化剂聚桂醇(PPI)及无水乙醇(PEI)对甲状腺囊性结节的有效性及安全性。方法系统检索万方数据知识平台、中国生物医学文献数据库(CBM)、中国期刊全文数据库(CNKI)、Web of Science、the Cochrane Library、EmBase和PubMed上有关注射硬化剂PPI治疗甲状腺囊性结节的随机对照试验。文献检索时间为建库至今。筛选文献、提取数据及文献的偏倚风险评价至少2名研究者独立完成,结果采用Cochrane软件RevMan5.3软件进行分析。结果纳入7篇随机对照研究,共918例患者,PPI组468例,PEI组450例,PPI组与PEI组治疗甲状腺囊性结节在有效性上差别无统计学意义(OR=1.10,95%CI(0.69,1.86),P=0.36),PPI组治疗甲状腺囊性结节术后并发症发生率小于PEI组,差异有统计学意义(OR=0.25,95%CI(0.17,0.35),P=0.77),所有试验均未报道死亡。结论超声引导下囊内注射PPI硬化治疗甲状腺囊性结节的临床疗效与PEI相似,但在术后并发症发生率上小于PEI组。
过敏性紫癜(Henoch-Schönlein purpura, HSP)又称为IgA血管炎,是由IgA免疫复合物沉积介导的全身性小血管炎。HSP以儿童最常见,成人较为少见。临床上以皮肤紫癜最多见,可伴有关节、胃肠道及肾脏等各系统症状。当腹部症状先于紫癜出现时,易被缺乏相关经验的临床医生误诊为急腹症、急性阑尾炎、消化道出血等疾病。现报道1例以腹部症状为主的成人混合型HSP,目的在于提高临床医生对HSP的诊治水平,避免延误患者的诊治。Henoch-Schönlein purpura (HSP), also known as IgA vasculitis, is a systemic small vasculitis mediated by IgA immune complex deposition. HSP is most common in children and less common in adults. The most common clinical skin purpura, can be accompanied by joint, gastrointestinal and kidney and other system symptoms. When the abdominal symptoms appear before purpura, it is easy to be misdiagnosed as acute abdomen, acute appendicitis, gastrointestinal bleeding and other diseases by clinicians who lack relevant experience. A case of adult mixed HSP with abdominal symptoms was reported in order to improve the diagnosis and treatment of HSP by clinicians and avoid delay in diagnosis and treatment.
暂无评论